|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Profit before income taxes | |||||
| Total profit before income taxes | |||||
| Profit for the year | |||||
| Total profit for the year | |||||
| Adjustments for: | |||||
| Interest income (Note 36) | |||||
| Interest expense (Note 36) | |||||
| Dividend income (Note 38) | |||||
| Income tax expense (Note 46) | |||||
| Total income tax expense (Note 46) | |||||
| Net fees and commission expense (Note 37) | |||||
| Net insurance income (Note 29) | |||||
| Net insurance finance expense (Note 30) | |||||
| Total net insurance finance expense (Note 30) | |||||
| Net gain on financial instruments at fair value through profit or loss (Note 39) | |||||
| Net gain on derivatives (Note 11) | |||||
| Net loss (gain) on financial instruments at fair value through profit or loss (overlay approach) (Note 9) | |||||
| Net loss (gain) on foreign currency translation | |||||
| Net loss (gain) on financial instruments designated at fair value through profit or loss (Note 40) | |||||
| Net loss (gain) on disposal of securities at fair value through other comprehensive income (Note 12) | |||||
| Provision for allowance for credit loss (Notes 41) | |||||
| Net loss (gain) on disposal of securities at amortized cost (Note 12) | |||||
| Employee benefit (Note 27) | |||||
| Depreciation and other amortization (Note 42) | |||||
| Other operating expense (Note 44) | |||||
| Equity method loss (income), net (Note 16) | |||||
| Other non-operating expense (Note 45) | |||||
| Sub-total | |||||
| Changes in assets and liabilities: | |||||
| Due from banks at amortized cost | |||||
| Securities at fair value through profit or loss | |||||
| Deposits at fair value through profit or loss | |||||
| Loans at fair value through profit or loss | |||||
| Financial instruments designated at fair value through profit or loss | |||||
| Derivative instruments | |||||
| Loans at amortized cost | |||||
| Insurance contract assets | |||||
| Reinsurance contract assets | |||||
| Other assets | |||||
| Deposits | |||||
| Net defined benefit liabilities | |||||
| Provisions | |||||
| Insurance contract liabilities | |||||
| Reinsurance contract liabilities | |||||
| Investment contract liabilities | |||||
| Other liabilities | |||||
| Sub-total | |||||
| Income taxes paid | |||||
| Interest received | |||||
| Interest paid | |||||
| Dividends received | |||||
| Net cash inflow from operating activities | |||||
| Total net cash inflow from operating activities | |||||
| Cash flows from investing activities | |||||
| Proceeds from disposal of financial instruments at fair value through profit or loss | |||||
| Acquisition of financial instruments at fair value through profit or loss | |||||
| Proceeds from disposal of securities at fair value through other comprehensive income | |||||
| Acquisition of securities at fair value through other comprehensive income | |||||
| Proceeds from disposal of securities at amortized cost | |||||
| Acquisition of securities at amortized cost | |||||
| Proceeds from disposal of property and equipment (Notes 14 and 45) | |||||
| Acquisition of property and equipment (Note 14) | |||||
| Proceeds from disposal of intangible assets (Notes 15 and 45) | |||||
| Acquisition of intangible assets (Note 15) | |||||
| Proceeds from disposal of investments in associates (Note 16) | |||||
| Acquisition of investments in associates (Note 16) | |||||
| Net cash inflow from loss of control | |||||
| Net cash outflow from acquisition of control | |||||
| Proceeds from disposal of investment property (Notes 17 and 45) | |||||
| Acquisition of investment property (Note 17) | |||||
| Proceeds from disposal of assets held for sale | |||||
| Change in other assets | |||||
| Proceeds from settlement of hedging derivative financial instruments | |||||
| Payment of settlement of hedging derivative financial instruments | |||||
| Net cash flows from business combinations | |||||
| Net cash inflow (outflow) from investing activities | |||||
| Total net cash inflow (outflow) from investing activities | |||||
| Cash flows from financing activities | |||||
| Issuance of hybrid bonds | |||||
| Redemption of hybrid bonds | |||||
| Net change in borrowings | |||||
| Proceeds from debt securities issued | |||||
| Redemption of debt securities issued | |||||
| Increase in financial liabilities designated at fair value through profit or loss | |||||
| Decrease in financial liabilities designated at fair value through profit or loss | |||||
| Changes in other liabilities | |||||
| Dividends paid | |||||
| Proceeds from settlement of hedging derivative financial instruments | |||||
| Payments of settlement of hedging derivative financial instruments | |||||
| Acquisition of treasury stock | |||||
| Disposal of treasury stock | |||||
| Expense for retirement of treasury stock | |||||
| Increase (decrease) in non-controlling interests | |||||
| Repayments of lease liabilities | |||||
| Payment of stock issuance costs | |||||
| Conversion costs for preferred stock to common stock | |||||
| Net cash inflow (outflow) from financing activities | |||||
| Total net cash inflow (outflow) from financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents held | |||||
| Total effect of exchange rate changes on cash and cash equivalents held | |||||
| Increase in cash and cash equivalents | |||||
| Cash and cash equivalents included in assets held for sale | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| IFRS Four | |||||
| Total cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at the end of the year | |||||
| Total cash and cash equivalents at the end of the year | |||||
Loading...